Serum Institute of India’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Serum Institute of India is a manufacturer and supplier of vaccines in India. Read more

Adar C. Poonawalla's photo - CEO of Serum Institute of India

CEO

Adar C. Poonawalla

CEO Approval Rating

71/100

Founded:

1966

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Biocon is the biggest rival of Serum Institute of India. Biocon is headquartered in Inn Bangalore, Karnataka, and was founded in 1978. Biocon is in the Pharmaceuticals field. Biocon generates 110% the revenue of Serum Institute of India.

Panacea Biotec is Serum Institute of India's #2 competitor. Panacea Biotec is a Private company that was founded in New Delhi, Delhi in null. Panacea Biotec is in the industry. Panacea Biotec has 3,900 fewer employees vs. Serum Institute of India.

Bharat Serums has been one of Serum Institute of India's top competitors. Bharat Serums's headquarters is in Mumbai, Maharashtra, and was founded in 1971. Bharat Serums competes in the Biotechnology field. Bharat Serums generates 14% of Serum Institute of India's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 4,000 a good estimate for Serum Institute of India's Employee count?

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Nanotherapeutics, Inc.

Apr 2017

Source »
$78.2M
Nanotherapeutics researches, discovers, develops, manufactures and distributes proteins, antibodies, viral vaccines and gene therapy drug products.

These are all the companies that Serum Institute of India has acquired. Serum Institute of India's latest acquisition was Nanotherapeutics, Inc. in Apr 2017. Nanotherapeutics researches, discovers, develops, manufactures and distributes proteins, antibodies, viral vaccines and gene therapy drug products.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

$56.5M
Sep 27, 2018
Series A
-
Visterra develops and commercializes antibody therapeutics for the treatment of pandemic influenza and chronic kidney diseases.
$23.6M
Oct 04, 2017
Series C
Jul 01, 2018

These are all the companies that Serum Institute of India has invested in. Serum Institute of India's latest investment was Nanotherapeutics, Inc. in Apr 2017. Nanotherapeutics researches, discovers, develops, manufactures and distributes proteins, antibodies, viral vaccines and gene therapy drug products.

Serum Institute of India News

September 16, 2020Reuters

source

Serum Institute of India has received Indian regulatory approval to resume local clinical trials of A... See more »
September 15, 2020Contract Pharma

Novavax, Serum Institute of India Enter COVID-19 Vax Mfg. Pact

Increases global production capacity for NVX-CoV2373 to over 2 billion doses annually as of 2021.... See more »
September 12, 2020Plunge Daily

DCGI

Serum Institute of India needs approval from the Data and Safety Monitoring Board (DSMB) in India and... See more »
September 11, 2020Trakin

Serum Stops COVID-19 Vaccine Trial In India; Russia Rolls Out Vaccine For Public

Serum Institute of India (SII) paused the trials of Covishield, Oxford University-AstraZeneca's COVID... See more »
September 10, 2020Business Recorder

AstraZeneca

LONDON: Drugs giant AstraZeneca on Thursday said a Covid-19 vaccine could still be available by as ea... See more »
September 10, 2020CBC News

Late-stage COVID-19 vaccine trial on pause due to possible serious side effect. Here's what that means

A front-running team in the race to develop a COVID-19 vaccine has put its trial on hold after a repo... See more »
September 9, 2020The Hindu

Coronavirus | Serum Institute pulled up for not pausing vaccine trial

AstraZeneca has placed global trials on hold after 'severe adverse reaction' in a volunteer.... See more »

Serum Institute of India Press Releases

December 17, 2018Business Wire India

Dr. Cyrus Poonawalla Congratulated for Life-Long Commitment to Boosting Vaccine Coverage in the World's Poorest Countries by the GAVI

Business Wire IndiaDr. Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Po... See more »
September 26, 2017NewsVoir

Serum Institute's Vaccine Demonstrates Significant Efficacy Against Severe Rotavirus Gastroenteritis

Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd. rotavirus va... See more »
March 6, 2017Blackbird

PharmaJet® partners with Serum Institute to Launch Needle-Free MMR Vaccine

GOLDEN, Colo., March 7, 2017 /PRNewswire/ - PharmaJet, the maker of innovative, needle-free injection... See more »
December 8, 2016EIN Presswire

Industry Research, Review, Growth, Segment and Analysis. Forecast to 2022

Tuberculosis Vaccine Treatment Market Information, by type of TB test, by TB vaccine type, by end use... See more »
December 1, 2016PressReleasePoint

GENTICEL successfully completes determining milestone in partnership with Serum Institute regarding use of GTL003 in multivalent vaccines

The Company has also been granted US patent protecting Vaxiclase and GTL003.read more... See more »
October 4, 2016NewsMaker

Global Rubella Vaccine Market 2016- China National Biotec Group, Serum Institute of India Ltd, Merck.

The Global Rubella Vaccine Industry 2016 Market Research Report is a professional and in-depth study ... See more »
June 20, 2016BriefingWire

Top 10 Clinical Research And Pharma Companies in Pune

The clinical trial industry is gaining continuously a positive metamorphosis in India.... See more »

Headquarters

212/2, Hadapsar, Off Soli Poonawalla Road

Pune, Maharashtra411028

91-20-2699-3900

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Serum Institute of India is a manufacturer and supplier of vaccines in India. Serum Institute of India was founded in 1966. Serum Institute of India's headquarters is located in Pune, Maharashtra, IN 411028. Serum Institute of India's latest acquisiti...

CEO

Serum Institute of India's CEO, Adar C. Poonawalla, currently has an approval rating of 71%. Serum Institute of India's primary competitors are Biocon, Panacea Biotec & Bharat Serums.

Website

seruminstitute.com

Frequently Asked Questions about Serum Institute of India

  1. When was Serum Institute of India founded?

    Serum Institute of India was founded in 1966
  2. Who is Serum Institute of India's CEO?

    Serum Institute of India's CEO is Adar C. Poonawalla
  3. How much revenue does Serum Institute of India generate?

    Serum Institute of India generates $693.7M in revenue
  4. How much funding does Serum Institute of India have?

    Serum Institute of India has historically raised $0 in funding
  5. Where is Serum Institute of India's headquarters?

    Serum Institute of India's headquarters is in Pune Maharashtra, IN
  1. How many employees does Serum Institute of India have?

    Serum Institute of India has 4,000 employees
  2. What sector does Serum Institute of India operate in?

    Serum Institute of India is in Health Care Equipment
  3. Who are Serum Institute of India's competitors?

    Serum Institute of India's top competitors are Biocon, Panacea Biotec, Bharat Serums
  4. Who has Serum Institute of India invested in?

    Serum Institute of India's has invested in companies such as X-vax Technology, Visterra